SCHEMBL7974303

SCHEMBL7974303

CN(Cc1nc2ncn(Cc3ccc(F)cc3)c2c(=O)[nH]1)C(=O)OC(C)(C)C

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 1/20 0.42
CACNA1G O43497 1/20 0.40
CACNA1B Q00975 1/20 0.40
CACNA1C Q13936 1/20 0.40
SMN1; SMN2 Q16637 3/20 0.39
ALDH1A1 P00352 3/20 0.39
LMNA P02545 1/20 0.38
KMT2A Q03164 1/20 0.37
POLB P06746 1/20 0.36
HTR2C P28335 2/20 0.35
SLC6A4 P31645 2/20 0.35
TYMS P04818 1/20 0.35
BRD4 O60885 1/20 0.35
HTR2A P28223 1/20 0.34
RIPK1 Q13546 1/20 0.34
HTT P42858 1/20 0.34
CCNE2 O96020 1/20 0.34
CCNE1 P24864 1/20 0.34
CDK2 P24941 1/20 0.34
MET P08581 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7987946 0.92 HPGD (0.42) HPGDCACNA1GCACNA1BCACNA1CSMN1; SMN2
SCHEMBL7992290 0.91 HPGD (0.42) HPGDCACNA1GCACNA1BCACNA1CSMN1; SMN2
SCHEMBL7985463 0.91 HPGD (0.52) HPGDCACNA1GCACNA1BCACNA1CSMN1; SMN2
SCHEMBL7975231 0.86 CACNA1G (0.40) HPGDCACNA1GCACNA1BCACNA1CSMN1; SMN2
SCHEMBL7988125 0.86 HPGD (0.43) HPGDCACNA1GCACNA1BCACNA1CSMN1; SMN2
SCHEMBL7974301 0.85 CACNA1G (0.40) HPGDCACNA1GCACNA1BCACNA1CSMN1; SMN2
SCHEMBL7988933 0.84 GAA (0.44) HPGDCACNA1GCACNA1BCACNA1CSMN1; SMN2
SCHEMBL7974300 0.82 HTR2C (0.37) HPGDCACNA1GCACNA1BCACNA1CALDH1A1
SCHEMBL7988916 0.82 HPGD (0.50) HPGDSMN1; SMN2ALDH1A1KMT2AHTR2C
SCHEMBL7991611 0.82 HPGD (0.42) HPGDCACNA1GCACNA1BCACNA1CSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed